Literature DB >> 8924255

High risk of HIV disease progression after infection through a sexual partner with AIDS.

N Carré1, L Meyer, F Boufassa, C Deveau, A Persoz, C Rouzioux, J L Vildé.   

Abstract

OBJECTIVE: To investigate whether HIV-1 infection acquired through a severely immunodepressed sexual partner increases the risk of disease progression.
DESIGN: A prospective cohort of patients infected through sexual contact at a known date and enrolled a few months (median, 2 months) after their first HIV-positive test. At enrolment, 12 subjects stated having had unprotected intercourse (anal or vaginal penetration) with a partner with AIDS within the 6 months prior to their first HIV-positive test. For the same period, 60 subjects stated having had unprotected intercourse with a partner, known to be HIV-positive, but who had not developed AIDS.
METHOD: The endpoint was the first occurrence of an HIV-related illness (group IV or AIDS, 1987 Centers for Disease Control and Prevention revised classification). Event-free survival curves since infection were constructed using the Kaplan-Meier method and compared by the log-rank test. The Cox model was used for multivariate analysis.
RESULTS: Disease progression was more rapid among the 12 subjects who stated having sex with a person with AIDS at a time close to infection, than among the other subjects (P = 0.03). Homosexuality and age at infection were also related to HIV disease progression. The adjusted relative risk of developing an HIV-related illness among those 12 subjects was 3.9 (95% confidence interval, 1.5-9.9).
CONCLUSION: Our results confirm the influence of virus-related factors on the onset of immunodepression in subjects infected through sexual contact.

Entities:  

Mesh:

Year:  1996        PMID: 8924255     DOI: 10.1097/00002030-199601000-00011

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  1 in total

1.  HIV infection and pregnancy status among adults attending voluntary counseling and testing in 2 developing countries.

Authors:  Andrew D Forsyth; Thomas J Coates; Olga A Grinstead; Gloria Sangiwa; Donald Balmer; Munkolenkole C Kamenga; Steven E Gregorich
Journal:  Am J Public Health       Date:  2002-11       Impact factor: 9.308

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.